Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phibro Animal Health

30.47
-0.0950-0.31%
Volume:133.41K
Turnover:4.08M
Market Cap:1.23B
PE:39.04
High:31.03
Open:30.67
Low:30.08
Close:30.56
Loading ...

BUZZ-Phibro rises after J.P. Morgan upgrades to 'overweight'

Reuters
·
07 Jul

Phibro Animal Health Raised to Overweight From Neutral by JP Morgan

Dow Jones
·
07 Jul

Phibro Animal Health upgraded to Overweight from Neutral at JPMorgan

TIPRANKS
·
07 Jul

U.S. RESEARCH ROUNDUP-Analog Devices, Constellation Brands, Phibro Animal Health

Reuters
·
07 Jul

Phibro Animal Health Corp : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $35 From $25

THOMSON REUTERS
·
07 Jul

Phibro Animal Health Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
26 Jun

Phibro Animal Health upgraded to Neutral from Underperform at BNP Paribas Exane

TIPRANKS
·
16 Jun

Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain?

Zacks
·
28 May

4 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks
·
23 May

Best Value Stocks to Buy for May 23rd

Zacks
·
23 May

Phibro Animal Health Corporation to Participate in Stifel Jaws & Paws Conference

Reuters
·
23 May

Phibro Animal Health Corp’s Earnings Call Highlights Robust Growth

TIPRANKS
·
13 May

Phibro Animal Health Reports Strong Q3 Results

TIPRANKS
·
09 May

Bank of America Securities Remains a Sell on Phibro Animal Health (PAHC)

TIPRANKS
·
09 May

Phibro Animal Health Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
08 May

Stock Track | Phibro Animal Health Soars 7.74% Pre-market as Morgan Stanley Boosts Price Target

Stock Track
·
08 May

Morgan Stanley Adjusts Price Target on Phibro Animal Health to $21 From $20, Maintains Equalweight Rating

MT Newswires Live
·
08 May

Stock Track | Phibro Animal Health Surges 5.98% Pre-market as Morgan Stanley Raises Price Target

Stock Track
·
08 May

Phibro Animal Health Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Phibro Animal Health Q3 Adj. EPS $0.63 Beats $0.52 Estimate, Sales $347.80M Miss $352.40M Estimate

Benzinga
·
08 May